US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist
  • 0.820
  • -0.037-4.35%
Close Mar 28 16:00 ET
  • 0.820
  • 0.0000.00%
Post 19:55 ET
184.26MMarket Cap-1.67P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-67.20%57.8M
269.78%7.55M
425.77%49.41M
-94.79%356K
-99.70%481K
58.34%176.23M
-92.50%2.04M
-64.48%9.4M
-76.73%6.84M
459.52%157.96M
Operating revenue
-67.20%57.8M
269.78%7.55M
425.77%49.41M
-94.79%356K
-99.70%481K
58.34%176.23M
-92.50%2.04M
-64.48%9.4M
-76.73%6.84M
459.52%157.96M
Cost of revenue
Gross profit
Operating expense
-47.07%156.25M
-47.43%33.54M
-45.38%38.78M
-54.13%36.27M
-41.42%47.66M
-5.55%295.22M
-22.77%63.81M
-12.72%71.01M
5.26%79.06M
10.70%81.35M
Selling and administrative expenses
-26.88%44.73M
-24.68%9.87M
-20.61%11.05M
-24.78%12.05M
-35.12%11.77M
-2.42%61.17M
-20.34%13.1M
-14.29%13.92M
6.10%16.01M
21.65%18.14M
-General and administrative expense
-26.88%44.73M
-24.68%9.87M
-20.61%11.05M
-24.78%12.05M
-35.12%11.77M
-2.42%61.17M
-20.34%13.1M
-14.29%13.92M
6.10%16.01M
21.65%18.14M
Research and development costs
-52.35%111.52M
-53.31%23.68M
-51.42%27.73M
-61.58%24.22M
-43.22%35.89M
-6.34%234.06M
-23.38%50.71M
-12.33%57.09M
5.04%63.05M
7.91%63.22M
Operating profit
17.27%-98.45M
57.92%-25.99M
117.26%10.63M
50.28%-35.91M
-161.58%-47.18M
40.88%-118.99M
-11.50%-61.76M
-12.23%-61.61M
-57.92%-72.23M
269.25%76.61M
Net non-operating interest income expense
-47.21%5.86M
45.24%2.17M
-96.33%129K
-63.24%1.03M
-23.02%2.54M
17.71%11.1M
-59.43%1.49M
98.70%3.52M
6.02%2.8M
145.38%3.29M
Non-operating interest income
-47.21%5.86M
45.24%2.17M
-96.33%129K
----
----
17.71%11.1M
-59.43%1.49M
98.70%3.52M
----
----
Total other finance cost
----
----
----
63.24%-1.03M
23.02%-2.54M
----
----
----
-6.02%-2.8M
-145.38%-3.29M
Other net income (expense)
96.44%-5.52M
0
97.72%-1.17M
92.57%-4.35M
-155.01M
-296K
-44.8M
-51.35M
-58.57M
Special income (charges)
96.44%-5.52M
--0
--0
97.72%-1.17M
92.57%-4.35M
---155.01M
---296K
---44.8M
---51.35M
---58.57M
-Less:Impairment of capital assets
-96.44%5.52M
--0
--0
-97.72%1.17M
-92.57%4.35M
--155.01M
--296K
--44.8M
--51.35M
--58.57M
Income before tax
62.68%-98.11M
60.67%-23.82M
110.46%10.76M
70.15%-36.05M
-329.71%-48.99M
-37.04%-262.9M
-17.12%-60.57M
-93.68%-102.89M
-180.27%-120.77M
148.56%21.33M
Income tax
96.71%-167K
-56.99%-427K
-93.07%88K
101.18%74K
-49.48%98K
-1,282.28%-5.07M
-205.02%-272K
4,133.33%1.27M
-7,739.02%-6.26M
234.48%194K
Net income
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
-95.96%-104.16M
-165.23%-114.51M
148.05%21.13M
Net income continuous Operations
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
-95.96%-104.16M
-165.23%-114.51M
148.05%21.13M
Minority interest income
Net income attributable to the parent company
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
-95.96%-104.16M
-165.23%-114.51M
148.05%21.13M
Preferred stock dividends
Other preferred stock dividends
1.29M
0
Net income attributable to common stockholders
62.01%-97.94M
61.20%-23.4M
109.01%9.39M
68.45%-36.13M
-332.29%-49.09M
-34.09%-257.83M
-16.01%-60.3M
-95.96%-104.16M
-165.23%-114.51M
148.05%21.13M
Basic earnings per share
66.89%-0.49
67.65%-0.11
108.47%0.05
72.73%-0.18
-307.69%-0.27
-18.40%-1.48
-6.25%-0.34
-73.53%-0.59
-127.59%-0.66
143.33%0.13
Diluted earnings per share
66.89%-0.49
67.65%-0.11
106.78%0.04
72.73%-0.18
-325.00%-0.27
-18.40%-1.48
-6.25%-0.34
-73.53%-0.59
-127.59%-0.66
140.00%0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -67.20%57.8M269.78%7.55M425.77%49.41M-94.79%356K-99.70%481K58.34%176.23M-92.50%2.04M-64.48%9.4M-76.73%6.84M459.52%157.96M
Operating revenue -67.20%57.8M269.78%7.55M425.77%49.41M-94.79%356K-99.70%481K58.34%176.23M-92.50%2.04M-64.48%9.4M-76.73%6.84M459.52%157.96M
Cost of revenue
Gross profit
Operating expense -47.07%156.25M-47.43%33.54M-45.38%38.78M-54.13%36.27M-41.42%47.66M-5.55%295.22M-22.77%63.81M-12.72%71.01M5.26%79.06M10.70%81.35M
Selling and administrative expenses -26.88%44.73M-24.68%9.87M-20.61%11.05M-24.78%12.05M-35.12%11.77M-2.42%61.17M-20.34%13.1M-14.29%13.92M6.10%16.01M21.65%18.14M
-General and administrative expense -26.88%44.73M-24.68%9.87M-20.61%11.05M-24.78%12.05M-35.12%11.77M-2.42%61.17M-20.34%13.1M-14.29%13.92M6.10%16.01M21.65%18.14M
Research and development costs -52.35%111.52M-53.31%23.68M-51.42%27.73M-61.58%24.22M-43.22%35.89M-6.34%234.06M-23.38%50.71M-12.33%57.09M5.04%63.05M7.91%63.22M
Operating profit 17.27%-98.45M57.92%-25.99M117.26%10.63M50.28%-35.91M-161.58%-47.18M40.88%-118.99M-11.50%-61.76M-12.23%-61.61M-57.92%-72.23M269.25%76.61M
Net non-operating interest income expense -47.21%5.86M45.24%2.17M-96.33%129K-63.24%1.03M-23.02%2.54M17.71%11.1M-59.43%1.49M98.70%3.52M6.02%2.8M145.38%3.29M
Non-operating interest income -47.21%5.86M45.24%2.17M-96.33%129K--------17.71%11.1M-59.43%1.49M98.70%3.52M--------
Total other finance cost ------------63.24%-1.03M23.02%-2.54M-------------6.02%-2.8M-145.38%-3.29M
Other net income (expense) 96.44%-5.52M097.72%-1.17M92.57%-4.35M-155.01M-296K-44.8M-51.35M-58.57M
Special income (charges) 96.44%-5.52M--0--097.72%-1.17M92.57%-4.35M---155.01M---296K---44.8M---51.35M---58.57M
-Less:Impairment of capital assets -96.44%5.52M--0--0-97.72%1.17M-92.57%4.35M--155.01M--296K--44.8M--51.35M--58.57M
Income before tax 62.68%-98.11M60.67%-23.82M110.46%10.76M70.15%-36.05M-329.71%-48.99M-37.04%-262.9M-17.12%-60.57M-93.68%-102.89M-180.27%-120.77M148.56%21.33M
Income tax 96.71%-167K-56.99%-427K-93.07%88K101.18%74K-49.48%98K-1,282.28%-5.07M-205.02%-272K4,133.33%1.27M-7,739.02%-6.26M234.48%194K
Net income 62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M-95.96%-104.16M-165.23%-114.51M148.05%21.13M
Net income continuous Operations 62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M-95.96%-104.16M-165.23%-114.51M148.05%21.13M
Minority interest income
Net income attributable to the parent company 62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M-95.96%-104.16M-165.23%-114.51M148.05%21.13M
Preferred stock dividends
Other preferred stock dividends 1.29M0
Net income attributable to common stockholders 62.01%-97.94M61.20%-23.4M109.01%9.39M68.45%-36.13M-332.29%-49.09M-34.09%-257.83M-16.01%-60.3M-95.96%-104.16M-165.23%-114.51M148.05%21.13M
Basic earnings per share 66.89%-0.4967.65%-0.11108.47%0.0572.73%-0.18-307.69%-0.27-18.40%-1.48-6.25%-0.34-73.53%-0.59-127.59%-0.66143.33%0.13
Diluted earnings per share 66.89%-0.4967.65%-0.11106.78%0.0472.73%-0.18-325.00%-0.27-18.40%-1.48-6.25%-0.34-73.53%-0.59-127.59%-0.66140.00%0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.